Epirubicin, Cisplatin, and Prolonged or Brief Infusional 5-Fluorouracil in the Treatment of Carcinoma of Unknown Primary Site

By Karapetis C.S.   Yip D.   Virik K.   Strickland A.   Ryder K.   Cowling M.   Harper P.G.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine and cisplatin in patients with carcinoma of unknown primary site

By Isik Metin  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 591-596

Humana Press, Inc

Access to resources Recommend Favorite

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

By Lee Jeeyun   Im Young-Hyuck   Cho Eun   Hong Yong   Lee Hyo   Kim Hyo   Kim Mi-Jin   Kim Kwhanmien   Kang Won   Park Keunchil   Shim Young  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

By                          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 425-428

Spandidos Publications

Access to resources Recommend Favorite

Thymidylate Synthase and Dihydropyrimidine Dehydrogenase are Related to Histological Effects of 5-Fluorouracil and Cisplatin Neoadjuvant Chemotherapy for Primary Gastric Cancer Patients

By Fukuda Hiroyuki   Takiguchi Nobuhiro   Koda Kenji   Oda Kenji   Seike Kazuhiro   Miyazaki Masaru  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 235-241

Informa Healthcare

Access to resources Recommend Favorite